⌘K

Login Start Free

Home/Filings/4/0001628280-23-023157

4//SEC Filing

Warren Eric 4

Accession 0001628280-23-023157

CIK 0001434868other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 4:45 PM ET

Size

18.0 KB

Accession

0001628280-23-023157

Insider Transaction Report

Form 4

Period: 2023-06-21

Esperion Therapeutics, Inc.ESPR

Chief Commercial Officer

Transactions

Sale
Common Stock
2023-06-21$1.48/sh−603$894→ 69,409 total

Footnotes (1)

[F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.

Documents

2 files

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1

filerCIK 0001916048

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 4:45 PM ET
Size: 18.0 KB

View on SEC.gov